Renato D. Covello
Department Of Otolaryngology Head & Neck Surgery
Rome, Italy
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
FAM19A4 and miR124-2 methylation status in human papillomavirus-driven and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Journal: Infectious agents and cancer
Published: May 30, 2025
BAG3 Positivity as Prognostic Marker in Head and Neck Squamous Cell Carcinoma.
Journal: Cancers
Published: April 04, 2025
Case Report: Malignant transformation of maxillary giant cell tumor of bone from EURACAN reference center.
Journal: Frontiers in oncology
Published: April 01, 2025
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 06, 2025
Liquid biopsy in head and neck cancer patients: blood, saliva, or both ?
Journal: Precision clinical medicine
Published: January 14, 2025
MRI in Oral Tongue Squamous Cell Carcinoma: A Radiomic Approach in the Local Recurrence Evaluation.
Journal: Current oncology (Toronto, Ont.)
Published: January 05, 2025
Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma.
Journal: BMC cancer
Published: September 09, 2024
Prediction of tumor response to neoadjuvant chemotherapy in high-grade osteosarcoma using clustering-based analysis of magnetic resonance imaging: an exploratory study.
Journal: La Radiologia medica
Published: April 30, 2024
A multicenter protocol to assess the prognostic significance of the tumor microenvironment in patients with squamous cell carcinoma of the larynx.
Journal: Head & neck
Published: April 20, 2024
Fetal Rhabdomyoma of the Larynx in an Adult.
Journal: Ear, nose, & throat journal
Published: April 09, 2024
Correction: Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Journal: Biomarker research
Published: March 27, 2024
Last Updated: 09/26/2026